Share
   
Title
Code
Session Type
Venue
Date Time
Co-Chairs:
Organizer:

With the availability of effective Point-of-Care (POC) molecular technology for Early Infant Diagnosis (EID) and viral load (VL) testing, ministries of health (MOHs), along with partners, have begun to implement routine POC testing in an effort to optimize laboratory networks and improve clinical outcomes. This session, featuring presentations by MOH officials and partners, will focus on sharing best practices and early results from research and routine use of POC molecular testing. Topics will include deployment strategies, maximizing the capacity of POC devices to perform multiple tests, including tuberculosis and hepatitis C (HCV), the experience of implementing routine POC testing for Early Infant Diagnosis (EID), the projected potential impacts of implementing the WHO recommendations for POC EID testing (WHO Consolidated Guidelines, June 2016), and the use of connectivity for remote monitoring of decentralized testing networks.

18:30
Introduction Video
Smiljka de Lussigny, Switzerland
Slides
18:35
TUSA1301
Welcome Address
18:45
TUSA1302
Comparing Conventional to Point-of-Care (POC) Early Infant Diagnosis (EID): Pre and post intervention data from a multi-country evaluation
Flavia Bianchi, United States
Slides
18:59
TUSA1303
Leveraging excess GeneXpert capacity to integrate HIV and TB testing services: A case study from Zimbabwe
Raiva Simbi, Zimbabwe
Slides
19:13
TUSA1304
Tracking manufacturer performance to ensure uninterrupted provision of timely, high quality EID test results
Esther Turunga, Switzerland
Slides
19:27
TUSA1305
Q&A
19:35
TUSA1306
Routine use of point-of-care EID testing in Côte d’Ivoire: Early lessons learnt
Patricia Fassinou, Cote D'Ivoire
Slides
19:49
TUSA1307
Patient impact and financial impact of implementing recommended WHO EID testing algorithm – at/near-birth testing, entry points, and POC
Jenna Mezhrahid, South Africa
Slides
20:03
TUSA1308
Using data to monitor POC device performance and error rates
Chishamiso Mudenyanga, Mozambique
Slides
20:17
TUSA1309
Q&A
20:25
TUSA1310
Closing Statements
Lara Vojnov, Switzerland
Chewe Luo, United States